BKS Advisors’s Novartis NVS Stock Holding History

BKS Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,797	Closed	-$230K	–	160
2015 Q3	$230K	Buy	+2,797	New	+$249K	0.13%	127

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

BKS Advisors's NVS Position: Q4 2015 in Review

BKS Advisors sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,797 shares — an estimated $230K sold.

BKS Advisors first reported a position in NVS in Q3 2015 and held it in 1 quarter. The position peaked at $230K in Q3 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

BKS Advisors reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
BKS Advisors sold 2,797 Novartis shares in Q4 2015, an estimated $230K.
BKS Advisors first reported a position in Novartis in Q3 2015 and held it in 1 quarter.
BKS Advisors's Novartis position peaked at $230K in Q3 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on BKS Advisors's 13F filing for Q4 2015, filed 2 Feb 2016.